Back
Incyte Vs. Syndax Pharmaceuticals Industry Stock Comparison
Buy
64
INCY
Incyte
Last Price:
77.29
Seasonality Move:
35.45%
Sell
38
SNDX
Syndax Pharmaceuticals
Last Price:
19.70
Seasonality Move:
8.62%
Buy
64
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $77.28. The Score for INCY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $19.69. The Score for SNDX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $19.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 80.26 | Buy |
| Chaikin Money Flow: | 1140547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.25 - 72.25) | Buy |
| Bollinger Bands (100): | (61.18 - 68.26) | Buy |
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 57.1 | Buy |
| Chaikin Money Flow: | 1326775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.56 - 19.6) | Buy |
| Bollinger Bands (100): | (18.47 - 21.89) | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.7 | Buy |
| 20-day SMA: | 68.51 | Buy |
| 50-day SMA: | 66.46 | Buy |
| 200-day SMA: | 60.94 | Buy |
| 8-day EMA: | 73.42 | Buy |
| 20-day EMA: | 70.01 | Buy |
| 50-day EMA: | 67.15 | Buy |
| 200-day EMA: | 63.04 | Buy |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.05 | Buy |
| 20-day SMA: | 19.09 | Buy |
| 50-day SMA: | 19.07 | Buy |
| 200-day SMA: | 20.97 | Sell |
| 8-day EMA: | 19.14 | Buy |
| 20-day EMA: | 19.08 | Buy |
| 50-day EMA: | 19.31 | Buy |
| 200-day EMA: | 20.12 | Sell |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.55 per share.
Incyte Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syndax Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||